PIK3CD and neoplasm: When we analysed growth of tumours from cells lacking PI3K-C2β, first we observed that these cells required six additional days to form tumours of the pre-assigned size to start docetaxel treatment (Fig. 7a), indicating that downregulation of the enzyme delayed tumours growth in the first weeks after cells implant in vivo.